Statistics
Publications
14
Citations
1.2K
H-Index
14
Active since
1995
Martin Rüdiger is an author at GlaxoSmithKline (United Kingdom) specializing in molecular biology, life sciences, and drug discovery.
Publications per year
1995–2021
14
14
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
Huw D. Lewis, John Liddle, Jim Coote et al. · Nature Chemical Biology · 2015 · 760 citations · Full text
Martin Rüdiger, Ulrich Haupts, Keith J. M. Moore et al. · SLAS DISCOVERY · 2001 · 59 citations · Full text
1–5 of 14